News

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in UNICEF & PAHO tenders in other markets.
Jiangsu Recbio Technology Company Limited, a leading Chinese biopharmaceutical company, today announced they have entered into a licensing cooperation agreement, and commenced the technology transfer ...
According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...
BE to produce and commercialise Recbio's nine-valent HPV vaccine in India and global markets, including participation in ...